Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals

Proc Soc Exp Biol Med. 1989 May;191(1):23-9. doi: 10.3181/00379727-191-42884.

Abstract

Interleukin 1 (IL-1) is a radioprotector of bone marrow and is cytotoxic to some tumor cells. This investigation examines these two properties in the same host animals and gives evidence of radioprotection against localized x-irradiation of the head and neck region. By LD50 analyses, recombinant human IL-1 (100 ng/mouse, approximately 3 micrograms/kg) was found to be radioprotective against whole-body irradiation for both C3H/Km and C57BL/Ka mice. The combined potency ratio for the two strains was 1.07 (95% confidence limit: 1.02-1.12). It was also radioprotective against the injury leading to acute lethality resulting from localized head and neck irradiation of C3H/Km mice; 100 ng of IL-1/mouse produced a potency ratio of 1.05 (95 confidence limit: 1.03-1.07). However, two tumors that originated in C3H/Km mice, RIF-1 and SCCVII, showed neither in vitro nor in vivo response to IL-1. Also, there was no IL-1-induced reduction in in vivo growth of the RL 12NP lymphoma in C57BL/Ka mice.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Carcinoma, Squamous Cell / drug therapy
  • Fibrosarcoma / therapy
  • Head / radiation effects
  • Interleukin-1 / pharmacology*
  • Interleukin-1 / therapeutic use
  • Lymphoma / drug therapy
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred C57BL
  • Neck / radiation effects
  • Neoplasms, Experimental / therapy*
  • Radiation-Protective Agents*
  • Recombinant Proteins / pharmacology
  • Tumor Cells, Cultured
  • Whole-Body Irradiation

Substances

  • Interleukin-1
  • Radiation-Protective Agents
  • Recombinant Proteins